EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Sweeteners: erythritol, xylitol and cardiovascular risk—friend or foe?

Bettina K Wölnerhanssen iD, Anne Christin Meyer-Gerspach iD, Arduino Arduini iD, Angelo D'Alessandro, Edoardo Gronda iD, Stefano Carugo iD, Mario Bonomini iD, Maurizio Gallieni iD, Valentina Masola iD, Anne Angelillo-Scherrer iD, Tommaso Prosdocimi iD, Gary D Lopaschuk iD

Cardiovascular Research · 2025

DOI: 10.1093/cvr/cvaf091 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cardiovascular Research, 2025. Verfasst von Bettina K Wölnerhanssen und 11 weiteren Autor:innen. Beteiligte Einrichtung: St. Clara Research Ltd at St. Claraspital, Kleinriehenstrasse 43, Basel CH-4058, Switzerland. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Erythritol, Xylitol, Sweetening Agents. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 132 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, Swiss National Science Foundation, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hyperglycaemia harms vascular health and promotes platelet aggregation. Reducing glucose concentration is crucial, and sugar alcohols may aid this effort. Used for over 50 years in food, cosmetic, and pharmaceutical industries, erythritol and xylitol minimally affect plasma glucose and insulin levels while promoting the release of beneficial gastrointestinal hormones such as e.g. glucagon-like peptide-1. These properties make them particularly appealing for individuals with diabetes, obesity, and metabolic syndrome. Recent pilot trials suggest that xylitol and erythritol might temporarily alter platelet aggregation. Studies on critically ill patients receiving large intravenous doses and Mendelian randomisation trials do not link sugar alcohols to significant cardiovascular risks. Sugar alcohols are also endogenously produced in the body, and while their increased production under certain conditions is not fully understood, it requires further research. This review discusses the physiology and metabolism of erythritol and xylitol, and other sugar alcohols, their roles in metabolomic profiling, effects on platelet aggregation and cardiovascular risk, related genetic disorders, vascular impacts, and usage in critically ill patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesErythritolXylitolSweetening AgentsBlood GlucoseHyperglycemiaHumansAnimalsRisk AssessmentPlatelet AggregationHeart Disease Risk FactorsBiomarkers

Stichwörter der Autor:innen

ErythritolSugar alcoholsThrombocyte aggregationVascular healthXylitol

Substanzen

ErythritolXylitolSweetening AgentsBlood GlucoseBiomarkers

Autor:innen und Institutionen

  • St. Clara Research Ltd at St. Claraspital, Kleinriehenstrasse 43, Basel CH-4058, Switzerland.
  • Faculty of Medicine, University of Basel, Basel 4001, Switzerland.
  • Department of Research and Development, Iperboreal Pharma Srl, Pescara 65121, Italy.
  • Research Department, CoreQuest Sagl, Lugano 6900, Switzerland.
  • Department of Biochemistry and Molecular Genetics, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
  • IRCCS Ca' Granda Foundation, Cardio Renal Program, UOC Nephrology, Dialysis and Adult Renal Transplant Program, Ospedale Maggiore Policlinico, Milan 20122, Italy.

ORCID-Profile: Bettina K Wölnerhanssen, Anne Christin Meyer-Gerspach, Arduino Arduini, Edoardo Gronda, Stefano Carugo, Mario Bonomini, Maurizio Gallieni, Valentina Masola, Anne Angelillo-Scherrer, Tommaso Prosdocimi, Gary D Lopaschuk

Förderung

  • NHLBI NIH HHS
  • Swiss National Science Foundation
  • NIGMS NIH HHS
  • NIH
  • University of Padova, Italy
  • University of Chieti-Pescara, Italy
  • Botnar Foundation
  • NIDDK NIH HHS

Zitieren

APA

Wölnerhanssen, B. K., Meyer-Gerspach, A. C., Arduini, A., D'Alessandro, A., Gronda, E., Carugo, S., Bonomini, M., Gallieni, M., Masola, V., Angelillo-Scherrer, A., Prosdocimi, T., & Lopaschuk, G. D. (2025). Sweeteners: erythritol, xylitol and cardiovascular risk—friend or foe?. Cardiovascular Research. https://doi.org/10.1093/cvr/cvaf091

Vancouver

Wölnerhanssen BK, Meyer-Gerspach AC, Arduini A, D'Alessandro A, Gronda E, Carugo S, et al. Sweeteners: erythritol, xylitol and cardiovascular risk—friend or foe?. Cardiovascular Research. 2025. doi:10.1093/cvr/cvaf091

BibTeX
@article{Wlnerhanssen2025,
  author = {Wölnerhanssen, Bettina K and Meyer-Gerspach, Anne Christin and Arduini, Arduino and D'Alessandro, Angelo and Gronda, Edoardo and Carugo, Stefano and Bonomini, Mario and Gallieni, Maurizio and Masola, Valentina and Angelillo-Scherrer, Anne and Prosdocimi, Tommaso and Lopaschuk, Gary D},
  title = {Sweeteners: erythritol, xylitol and cardiovascular risk—friend or foe?},
  journal = {Cardiovascular Research},
  year = {2025},
  doi = {10.1093/cvr/cvaf091}
}
Kostenlos starten →